Association between post-operative hPG(80) (circulating progastrin) detectable level and worse prognosis in glioblastoma

BACKGROUND: Patients with glioblastomas have a dismal prognosis, and there is no circulating predictive or prognostic biomarker. Circulating progastrin, hPG(80), is a tumor-promoting peptide present in the blood of patients with various cancers that has been shown to have prognostic value. We evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Doucet, L., Cailleteau, A., Vaugier, L., Gourmelon, C., Bureau, M., Salaud, C., Roualdes, V., Samarut, E., Aumont, M., Zenatri, M., Loussouarn, D., Quillien, V., Bocquet, F., Payen-Gay, L., Joubert, D., Prieur, A., Robert, M., Frenel, J.-S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594012/
https://www.ncbi.nlm.nih.gov/pubmed/37713930
http://dx.doi.org/10.1016/j.esmoop.2023.101626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594012/
https://www.ncbi.nlm.nih.gov/pubmed/37713930
http://dx.doi.org/10.1016/j.esmoop.2023.101626

Ejemplares similares